Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphocytic Leukemia, B Cell, Acute”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06124157
What this trial is testing

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Who this might be right for
B Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 222
Early research (Phase 1)Looking for participantsNCT06462365
What this trial is testing

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Who this might be right for
Hematologic MalignancyGvHDGVHD,Acute+8 more
Tr1X, Inc. 36
Early research (Phase 1)Study completedNCT01164709
What this trial is testing

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMature T-cell and Nk-cell Neoplasms+1 more
Swiss Cancer Institute 18
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04546399
What this trial is testing

Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Who this might be right for
Down SyndromeRecurrent B Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 461
Large-scale testing (Phase 3)UnknownNCT00020865
What this trial is testing

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionLeukemia+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00818961
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Northside Hospital, Inc. 36
Early research (Phase 1)Study completedNCT02226861
What this trial is testing

Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)+2 more
National Heart, Lung, and Blood Institute (NHLBI) 24
Testing effectiveness (Phase 2)Study completedNCT02065154
What this trial is testing

Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome+3 more
University of Alabama at Birmingham 39
Early research (Phase 1)Study completedNCT00104975
What this trial is testing

Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Yale University 20
Large-scale testing (Phase 3)Looking for participantsNCT06882057
What this trial is testing

Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol

Who this might be right for
Acute Lymphoblastic Leukemia ALLChildhood Leukemia, Acute LymphoblasticB Cell Acute Lymphoblastic Leukemia (B-ALL)
Institute of Hematology & Blood Diseases Hospital, China 3,000
Early research (Phase 1)Active Not RecruitingNCT01860937
What this trial is testing

T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed B-Cell Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)Looking for participantsNCT04329728
What this trial is testing

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Who this might be right for
Lymphoid Malignancies
AVM Biotechnology Inc 144
Early research (Phase 1)Study completedNCT00003243
What this trial is testing

Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableWithdrawnNCT00900120
What this trial is testing

Collecting and Storing Blood Samples From Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
University of Medicine and Dentistry of New Jersey
Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Not applicableStudy completedNCT01553162
What this trial is testing

Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 20
Early research (Phase 1)Study completedNCT01497184
What this trial is testing

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 95
Early research (Phase 1)Study completedNCT00079378
What this trial is testing

Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Looking for participantsNCT04746209
What this trial is testing

Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-Cell ALL, Childhood
Medical College of Wisconsin 25
Next Page